Insights from 2023 ESMO Annual Meeting

 

Insights from 2023 ESMO Annual Meeting
H

ESMO 2023 Insights: "Androgen Receptor Pathway Inhibitors or Taxanes for Patients With mCRPC - A Direct Comparison in ProBio, a Randomized, Outcome-Adaptive, Biomarker-Driven Platform Trial"

By Insights from 2023 ESMO Annual Meeting FEATURING Henrik Grönberg
By Insights from 2023 ESMO Annual Meeting FEATURING Henrik Grönberg
76 views
October 30, 2023
0 Comments
Login to view comments. Click here to Login
Genitourinary
09:09
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "PSMA PET-Directed Outcomes in mHSPC: Impli…

Feat. H. Abdel-Aty
03:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Prognostic Role of Metastatic Site in Pati…

Feat. E. Yekedüz
08:30
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Association of Health-Related Quality of L…

Feat. M. Morris
05:58
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Test…

Feat. A. Meuleman
05:29
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Real-World OS With Enzalutamide & Abir…

Feat. D. George
03:52
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "ARASENS Trial - PSA Outcomes With Daroluta…

Feat. F. Saad
31:30
Insights from 2023 ESMO Annual Meeting

ESMO23 Highlights in Urothelial Carcinoma

Feat. G. Sonpavde, B. McGregor
08:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The BonEnza Study - Changes in Bone Minera…

Feat. A. Dalla Volta
08:56
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment…

Feat. M. Voss
08:26
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro…

Feat. V. Koshkin
11:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Bladder Preservation Strategies - A Surgeo…

Feat. J. Boormans
04:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EMBARK Secondary Endpoints - Enzalutamide …

Feat. U. De Giorgi
14:06
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The DAD Trial - SG+EV as ≥ 2L Therapy for …

Feat. B. McGregor
09:35
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of …

Feat. G. de Velasco
10:48
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "[177 Lu]Lu-PSMA-617 in Taxane-Naïve Patien…

Feat. O. Sartor
13:49
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "THOR Study - Erdafitinib vs. Pembrolizumab…

Feat. A. Siefker-Radtke
06:25
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "The Tide-A Study - Avelumab + Intermittent…

Feat. R. Iacovelli
06:22
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "CABASTY Trial - Pain Response and HRQL Ana…

Feat. S. Oudard
05:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "EV-302/KEYNOTE-A39 Study of Enfortumab Ved…

Feat. T. Powles
22:19
Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Feat. G. Sonpavde
03:49
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Effect of Rapid Ultra-Low Prostate-Specifi…

Feat. A. Merseburger
06:52
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Androgen Receptor Pathway Inhibitors or Ta…

Feat. H. Grönberg
04:59
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Post Hoc Analysis of the CLEAR Trial - Tum…

Feat. V. Grünwald
10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland
07:53
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "LITESPARK-005 Study - Belzutifan vs. Evero…

Feat. L. Albiges